Clinical OMICs - Issue 4 - (Page 19)

Clinical OMICs NEW PRODUCTS Pharmacogenomic Test C. difficile Diagnostic Kit The GeneSight® Psychotropic test has just been enhanced to help clinicians make individualized antidepressant and antipsychotic medication decisions for patients with depression, anxiety, posttraumatic stress disorder, bipolar disorder, schizophrenia, and other behavioral health disorders. GeneSight Psychotropic now covers 38 FDA-approved medications including levomilnacipran (Fetzima®) and vortioxetine (Brintellix®). Assurex Health www.assurexhealth.com The artus C. difficile QS-RGQ MDx kit has been cleared by the U.S. FDA to qualitatively detect the healthcareassociated infection Clostridium difficile. The kit, which runs on the QIAsymphony RGQ MDx platform, can provide reliable detection of both the Toxin A and Toxin B of the infection. QIAsymphony RGQ MDx is a modular system for handling laboratory workflows. Its three modules are QIAsymphony SP for sample preparation, QIAsymphony AS for assay setup, and the real-time PCR detection platform Rotor-Gene Q MDx. Qiagen www.qiagen.com DNA Sequencing Test for Neurodevelopmental Disorders Genomic Lymphoma Tests MatBA® for follicular lymphoma (MatBA®-FL) and mantle-cell lymphoma (MatBA®-MCL) assist clinicians in the prognosis of follicular lymphoma (FL) and mantle-cell lymphoma (MCL). MatBAFL identifies genomic aberrations that are associated with the high frequency of transformation of FL into diffuse large B-cell lymphoma and shorter overall survival (OS). MatBA-MCL identifies genomic aberrations that are associated with high frequency of either a leukemic involvement and/or shorter OS. Cancer Genetics www.cancergenetics.com www.clinicalomics.com The devSEEK™ sequence analysis for neurodevelopmental disorders panel focuses on more than 100 genes known to be causative of neurodevelopmental disorders including autism spectrum disorders. Test results provide information that may be used to identify a known genetic cause and, to direct care and services for the patient. Courtagen Life Sciences www.courtagen.com May 29, 2014 Clinical OMICs 19 http://www.assurexhealth.com http://www.qiagen.com http://www.courtagen.com http://www.cancergenetics.com http://www.clinicalomics.com

Table of Contents for the Digital Edition of Clinical OMICs - Issue 4

Contents

Clinical OMICs - Issue 4